ADARx Pharmaceuticals(ADRX)
$13.82-0.18 (-1.29%)
ADRX
ADARx Pharmaceuticals ownership
$13.82
At close:-0.18 (-1.29%)
ADARx Pharmaceuticals (ADRX) Ownership - Who Owns ADARx Pharmaceuticals?
9 Followers
ADARx Pharmaceuticals (ADRX) Ownership Overview
- 29.02% Insiders
- 57.64% Other Institutional Investors
- 0.05% ETFs
- 13.29% Public Companies and Individual Investors
The ownership structure of ADARx Pharmaceuticals (ADRX) stock is a mix of institutional, retail, and individual investors. Approximately 57.69% of the company’s stock is owned by Institutional Investors, 29.02% is owned by Insiders, and 13.29% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of ADARx Pharmaceuticals (ADRX) stock is a mix of institutional, retail, and individual investors. Approximately 57.69% of the company’s stock is owned by Institutional Investors, 29.02% is owned by Insiders, and 13.29% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 29, 2026 | Erez Chimovits | $1,045,772 | |
| Sep 29, 2026 | Orbimed Advisors Llc | $16,150,000 | |
| Sep 29, 2026 | Carl Gordon | $16,150,000 | |
| Sep 28, 2026 | Sr One Capital Management, Llc | $27,200,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | $46,582,033 | ||
| Sep 30, 2026 | Woodline Partners Lp | $29,181,751 | |
| Sep 30, 2026 | Perceptive Advisors Llc | $5,982,000 | |
| Sep 30, 2026 | Blackstone Inc. | $8,408,718 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Lav Biosciences Fund V, L.p. | 11,858,655 | Insider | 10.66% | 166,021,170 |
| Sr One Capital Management, Llc | 9,936,661 | Insider | 8.94% | 139,113,254 |
| Erez Chimovits | 9,292,025 | Insider | 8.36% | 130,088,350 |
| BlackRock, Inc. | 2,336,110 | Institution | 2.10% | 32,705,540 |
| Michael Rockefeller | 1,463,478 | Institution | 1.32% | 20,488,692 |
| Orbimed Advisors Llc | 588,235 | Insider | 0.53% | 8,235,290 |
| Carl Gordon | 588,235 | Insider | 0.53% | 8,235,290 |
| Stephen A. Schwarzman | 421,701 | Institution | 0.38% | 5,903,814 |
| Joseph Edelman | 300,000 | Institution | 0.27% | 4,200,000 |
| Vanguard | 46,894 | Institution | 0.04% | 656,516 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total Stock Market ETF, VTI ETF | 30,645 | Institution | 0.03% | 520,965 |
| Vanguard Extended Market ETF, VXF ETF | 11,701 | Institution | 0.01% | 198,917 |
| T. Rowe Price Health Care ETF, TMED ETF | 5,802 | Institution | <0.01% | 78,733 |
| Vanguard Russell 2000 ETF, VTWO ETF | 4,004 | Institution | <0.01% | 68,068 |
| T. Rowe Price Biotech ETF, TDNA ETF | 1,359 | Institution | <0.01% | 18,442 |
| T. Rowe Price Small Cap ETF, TSEE ETF | 453 | Institution | <0.01% | 6,147 |
| Vanguard Russell 2000 Growth ETF, VTWG ETF | 402 | Institution | <0.01% | 6,834 |
| Fidelity Global Equity+ Balanced Fund Trust Units, TSE:FGEB ETF | 274 | Institution | <0.01% | 7,785 |
| Vanguard Russell 2000 Value ETF, VTWV ETF | 142 | Institution | <0.01% | 2,414 |
FAQ
Who Owns ADARx Pharmaceuticals (ADRX)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 57.69% of the company's stock is held by institutional investors, 29.02% is held by insiders, and 13.29% is held by public companies and individual investors.
What percentage of ADARx Pharmaceuticals (ADRX) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 57.69% of ADARx Pharmaceuticals (ADRX) stock is held by institutional investors: 0.05% by ETFs and 57.64% by other institutional investors.
What percentage of ADARx Pharmaceuticals (ADRX) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 13.29% of ADARx Pharmaceuticals (ADRX) stock is held by public companies and individual investors.
Who owns the most shares of ADARx Pharmaceuticals (ADRX)?
LAV Biosciences Fund V, L.P. owns the most shares of ADARx Pharmaceuticals (ADRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

